Pancreatic Cancer Research

ResearcherUniversity of Illinois ChicagoNo recent work listed

Navin Viswakarma

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-9837-2619; OpenAlex author ID A5089191106. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2019: 1 paper · 2020: none · 2021: 1 paper

Papers 2

  1. Mixed Lineage Kinase 3 phosphorylates prolyl-isomerase PIN1 and potentiates GLI1 signaling in pancreatic cancer development. Co-author DOI 10.1016/j.canlet.2021.04.015↗
  2. TGFβ Blockade Augments PD-1 Inhibition to Promote T-Cell-Mediated Regression of Pancreatic Cancer. Co-author DOI 10.1158/1535-7163.mct-18-0850↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Daniel R. Principe · 2 shared papers, 2019–2021 · strength 0.21
  2. Sandeep Kumar · 2 shared papers, 2019–2021 · strength 0.21
  3. Ajay Nmn Rana · 2 shared papers, 2019–2021 · strength 0.21
  4. Paul J. Grippo · 2 shared papers, 2019–2021 · strength 0.21
  5. Pier Cristoforo Giulianotti · 1 shared paper, 2021 · strength 0.12
  6. Carolina Torres · 1 shared paper, 2019 · strength 0.09
  7. Hidayatullah G. Munshi · 1 shared paper, 2019 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.